ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases

Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps. (J Am Coll Cardiol 2023;82:721-734) & COPY; 2023 by the American College of Cardiology Foundation.

Automated summary

Valvular heart disease (VHD) is a common condition that poses challenges in diagnosis and management. Guidelines have been developed by various organizations to provide optimal care for patients with VHD. This review compares and highlights the consistencies, discrepancies, and research gaps between the guidelines provided by the American College of Cardiology, American Heart Association, European Society of Cardiology, and European Association for Cardio-Thoracic Surgery.